4.7 Article

Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

Shundong Cang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)

Review Pharmacology & Pharmacy

Targeting focal adhesion kinase signaling in tumor growth and metastasis

Joerg Schwock et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Article Hematology

FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells

Yi Le et al.

AMERICAN JOURNAL OF HEMATOLOGY (2009)

Article Oncology

Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia

Emmanuelle Tavernier-Tardy et al.

LEUKEMIA RESEARCH (2009)

Review Medicine, General & Internal

Acute lymphoblastic leukaemia

Ching-Hon Pui et al.

LANCET (2008)

Article Biochemistry & Molecular Biology

New concepts regarding focal promotion of cell migration adhesion kinase and proliferation

Braden D. Cox et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2006)

Article Biochemical Research Methods

Design and cloning of lentiviral vectors expressing small interfering RNAs

Gustavo Tiscornia et al.

NATURE PROTOCOLS (2006)

Article Biochemical Research Methods

Production and purification of lentiviral vectors

Gustavo Tiscornia et al.

NATURE PROTOCOLS (2006)

Review Medicine, General & Internal

Mechanisms of disease: Acute lymphoblastic leukemia

C Pui et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)